Receptor targeting of adeno-associated virus vectors
- 30 June 2003
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (14) , 1142-1151
- https://doi.org/10.1038/sj.gt.3301976
Abstract
Adeno-associated virus (AAV) is a promising vector for human somatic gene therapy. However, its broad host range is a disadvantage for in vivo gene therapy, because it does not allow the selective tissue- or organ-restricted transduction required to enhance the safety and efficiency of the gene transfer. Therefore, increasing efforts are being made to target AAV-2-based vectors to specific receptors. The studies summarized in this review show that it is possible to target AAV-2 to a specific cell. So far, the most promising approach is the genetic modification of the viral capsid. However, the currently available AAV-2 targeting vectors need to be improved with regard to the elimination of the wild-type AAV-2 tropism and the improvement of infectious titers. The creation of highly efficient AAV-2 targeting vectors will also require a better understanding of the transmembrane and intracellular processing of this virus.Keywords
This publication has 62 references indexed in Scilit:
- Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface ReceptorsJournal of Virology, 2002
- Insertional Mutagenesis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors Targeted to Alternative Cell-Surface ReceptorsHuman Gene Therapy, 2001
- Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene TransferJournal of Virology, 2001
- Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus CapsidsMolecular Therapy, 2001
- Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome DegradationJournal of Virology, 2001
- Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical UseHuman Gene Therapy, 1999
- Functional Mimicry of Protein A of Staphylococcus aureus by a Proteolytically Cleaved FragmentBiochemical and Biophysical Research Communications, 1999
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Integrins as virus receptorsCurrent Biology, 1993
- Identification of the Arg‐Gly‐Asp sequence in laminin A chain as a latent cell‐binding site being exposed in fragment P1FEBS Letters, 1990